Patents by Inventor Keith Robert Willison

Keith Robert Willison has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120156689
    Abstract: A method of determining an analyte parameter is described for an analyte in a detection region having at least one analyte binding zone. The method includes detecting presence of an analyte element bound at the binding zone, incrementing or decrementing a count and preventing recount of the element to obtain absolute quantification.
    Type: Application
    Filed: July 14, 2010
    Publication date: June 21, 2012
    Applicant: IMPERIAL INNOVATIONS LIMITED
    Inventors: Keith Robert Willison, David R. Klug, Oscar Ces, Edward Burgin, Ali Salehi-Reyhani, Joseph John Kaplinsky
  • Publication number: 20090239250
    Abstract: The present invention provides an improved method of analysing and obtaining reliable data about the plasma membrane of single cells, using a microfluidic cell analyser. The microfluidic cell analyser of the invention comprises a single cell trap, a manipulator arranged to manipulate the outer surface of a cell in the trap, a detection zone in communication with the single cell trap and a detector.
    Type: Application
    Filed: December 1, 2005
    Publication date: September 24, 2009
    Applicant: Imperial Innovations Limited
    Inventors: David R. Klug, de Mello Andrew, Richard H. Templer, Paul Michael William French, Mark Andrew Aquilla Neil, Oscar Ces, Peter Joseph Jacques Parker, Keith Robert Willison
  • Patent number: 6255070
    Abstract: Nucleic acid encoding subunits of a polypeptide folding complex containing TCp-1 is useful in expression of the subunits for assembly of the complex in vitro or in vivo. The complex promotes folding of polypeptides, such as tubulin, e.g., following recombinant expression. The sequences share a high degree of homology but the C-termini are sufficiently different to enable peptides with sequences derived therefrom to be used in obtaining antibodies specific for the various subunits, i.e., able to distinguish between them. The antibodies may be used in analysis and design of complexes able to fold different polypeptides.
    Type: Grant
    Filed: October 11, 1996
    Date of Patent: July 3, 2001
    Assignee: Cancer Research Campaign Technology Limited
    Inventors: Keith Robert Willison, Hiroshi Kubota, Alan Ashworth